77 related articles for article (PubMed ID: 7502829)
1. Induction of specific immunity at mucosal surfaces: prospects for vaccine development.
Czerkinsky C; Quiding M; Eriksson K; Nordström I; Lakew M; Wenerås C; Kilander A; Björck S; Svennerholm AM; Butcher E
Adv Exp Med Biol; 1995; 371B():1409-16. PubMed ID: 7502829
[TBL] [Abstract][Full Text] [Related]
2. Exploration of mucosal immunity in humans: relevance to vaccine development.
Czerkinsky C; Holmgren J
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():37-44. PubMed ID: 7950860
[TBL] [Abstract][Full Text] [Related]
3. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
4. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
Lycke N; Holmgren J
Immunology; 1986 Oct; 59(2):301-8. PubMed ID: 3021614
[TBL] [Abstract][Full Text] [Related]
5. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
6. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
[TBL] [Abstract][Full Text] [Related]
7. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
8. The mucosal immune system for vaccine development.
Lamichhane A; Azegamia T; Kiyonoa H
Vaccine; 2014 Nov; 32(49):6711-23. PubMed ID: 25454857
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
10. Mucosal responses to parenteral and mucosal vaccines.
Kaul D; Ogra PL
Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
[TBL] [Abstract][Full Text] [Related]
11. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development.
Czerkinsky C; Svennerholm AM; Holmgren J
Clin Infect Dis; 1993 Mar; 16 Suppl 2():S106-16. PubMed ID: 8452962
[TBL] [Abstract][Full Text] [Related]
12. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells.
Saitoh-Inagawa W; Hiroi T; Yanagita M; Iijima H; Uchio E; Ohno S; Aoki K; Kiyono H
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):138-44. PubMed ID: 10634613
[TBL] [Abstract][Full Text] [Related]
13. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.
Quiding M; Nordström I; Kilander A; Andersson G; Hanson LA; Holmgren J; Czerkinsky C
J Clin Invest; 1991 Jul; 88(1):143-8. PubMed ID: 1905327
[TBL] [Abstract][Full Text] [Related]
14. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
Nyström J; Raghavan S; Svennerholm AM
Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
[TBL] [Abstract][Full Text] [Related]
16. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
[TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
[TBL] [Abstract][Full Text] [Related]
18. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
Harakuni T; Sugawa H; Komesu A; Tadano M; Arakawa T
Infect Immun; 2005 Sep; 73(9):5654-65. PubMed ID: 16113283
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization using recombinant plant-based oral vaccines.
Streatfield SJ
Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues.
Imaoka K; Miller CJ; Kubota M; McChesney MB; Lohman B; Yamamoto M; Fujihashi K; Someya K; Honda M; McGhee JR; Kiyono H
J Immunol; 1998 Dec; 161(11):5952-8. PubMed ID: 9834076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
